	Despesas De Vendas E Administração		Data
Alaunos Therapeutics	USD 585K	260K	2025-09
Alnylam Pharmaceuticals	USD 262.59M	60.72M	2025-09
Alterity Therapeutics Limited	AUD 2.29M	649.1K	2023-06
Amgen	USD 1.94B	237M	2025-12
Bayer	EUR 3.4B	140M	2025-09
BioCryst Pharmaceuticals	USD 80.47M	15.39M	2024-12
Biogen	USD 545.2M	38.6M	2025-09
BioMarin Pharmaceutical	USD 223.42M	8.86M	2025-09
Cipla	INR 13.25B	101.8M	2025-12
Clal Biotechnology	ILS 3.31M	513K	2022-12
Compugen	USD 2.33M	50K	2025-09
CSL	USD 727M	453M	2025-06
Gilead Sciences	USD 1.35B	6M	2025-09
GlaxoSmithKline	GBP 2.68B	518M	2025-12
Grifols	EUR 333.1M	157M	2025-09
Ionis Pharmaceuticals	USD 86.56M	4.04M	2025-09
J&J	USD 6.75B	831M	2025-12
Karyopharm Therapeutics	USD 27.19M	442K	2024-12
Merck	USD 2.85B	215M	2025-12
Novartis	USD 3.31B	134M	2025-09
Omeros	USD 11.32M	2.48M	2024-09
Pfizer	USD 4.08B	894M	2025-12
Roche Holding	CHF 7.28B	3.99B	2025-12
Sangamo BioSciences	USD 9.64M	1.83M	2024-06
Sanofi	EUR 2.75B	455M	2025-12
Sarepta Therapeutics	USD 77.11M	7.22M	2025-09
Tectonic Therapeutic	USD 4.96M	190K	2025-09
Ultragenyx Pharmaceutical	USD 86.62M	26K	2025-09
Vertex Pharmaceuticals	USD 445.1M	20.5M	2025-09

Sangamo BioSciences Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.